Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.
Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.
Digital security-focused, operator-led firm that co-founds and incubates formative-stage companies alongside world-class technologists, presenting hands-on founder support from leaders who've built flagship security companies.
Led by a solo GP, an early institutional investor that uses a learn-first networking approach—deep founder/category diligence—with bi-regional Columbus–Boulder presence centered on consumer, fashion, health/wellness, and brand+tech SaaS/IoT Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Specializes entirely on AI-first businesses in technical domains (defense, robotics, drug discovery, AI infrastructure), utilizing the entrepreneur’s extensive AI analysis visibility and a press arm that fosters lab-to-lab debates.
